Acurx Pharmaceuticals has announced plans to allocate up to $1 million worth of Bitcoin to its treasury reserves. The decision aligns with a growing trend among companies embracing Bitcoin as a store of value. The CEO of Acurx highlighted the appeal of Bitcoin as a treasury reserve asset, citing its limited supply and inflation-resistant properties. The company's move is purely a financial strategy and will not affect its drug development efforts. Acurx's decision mirrors the approach taken by MicroStrategy, which has accumulated a significant amount of Bitcoin in its treasury. The announcement comes amidst Bitcoin's all-time high prices and anticipation of further gains in a crypto-friendly regulatory environment.



Other News from Today